NO965458D0 - Stabiliserte nanopartikler som er filtrerbare under sterile betingelser - Google Patents

Stabiliserte nanopartikler som er filtrerbare under sterile betingelser

Info

Publication number
NO965458D0
NO965458D0 NO965458A NO965458A NO965458D0 NO 965458 D0 NO965458 D0 NO 965458D0 NO 965458 A NO965458 A NO 965458A NO 965458 A NO965458 A NO 965458A NO 965458 D0 NO965458 D0 NO 965458D0
Authority
NO
Norway
Prior art keywords
sterile conditions
under sterile
stabilized nanoparticles
filterable
filterable under
Prior art date
Application number
NO965458A
Other languages
English (en)
Norwegian (no)
Other versions
NO965458L (no
Inventor
Michel Laborie
Joel Vacus
Thierry Verrecchia
Marie-Christine Bissery
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO965458D0 publication Critical patent/NO965458D0/no
Publication of NO965458L publication Critical patent/NO965458L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/795—Composed of biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Filtering Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Materials For Medical Uses (AREA)
NO965458A 1994-06-22 1996-12-18 Stabiliserte nanopartikler som er filtrerbare under sterile betingelser NO965458L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9407628A FR2721510B1 (fr) 1994-06-22 1994-06-22 Nanoparticules filtrables dans des conditions stériles.
PCT/FR1995/000813 WO1995035101A1 (fr) 1994-06-22 1995-06-20 Nanoparticules stabilisees et filtrables dans des conditions steriles

Publications (2)

Publication Number Publication Date
NO965458D0 true NO965458D0 (no) 1996-12-18
NO965458L NO965458L (no) 1996-12-18

Family

ID=9464490

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965458A NO965458L (no) 1994-06-22 1996-12-18 Stabiliserte nanopartikler som er filtrerbare under sterile betingelser

Country Status (21)

Country Link
US (1) US6146663A (es)
EP (1) EP0766555B1 (es)
JP (1) JP3806937B2 (es)
CN (1) CN1151114A (es)
AT (1) ATE174791T1 (es)
AU (1) AU2797995A (es)
BR (1) BR9508363A (es)
CA (1) CA2192712A1 (es)
CZ (1) CZ377296A3 (es)
DE (1) DE69506867T2 (es)
DK (1) DK0766555T3 (es)
ES (1) ES2126905T3 (es)
FI (1) FI965165A (es)
FR (1) FR2721510B1 (es)
HU (1) HUT76549A (es)
MX (1) MX9606490A (es)
NO (1) NO965458L (es)
PL (1) PL317893A1 (es)
SK (1) SK166696A3 (es)
WO (1) WO1995035101A1 (es)
ZA (1) ZA955047B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092563A1 (en) * 1996-10-01 2007-04-26 Abraxis Bioscience, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
KR101180181B1 (ko) * 1997-06-27 2012-09-05 아브락시스 바이오사이언스, 엘엘씨 나노 입자 및 그의 제조 방법
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
JP4751556B2 (ja) 2000-02-28 2011-08-17 ジーンシーグス， インコーポレイテッド ナノカプセルカプセル化システムおよび方法
CA2309575A1 (en) * 2000-05-26 2001-11-26 James E. Guillet Internally cross-linked macromolecules
US6607784B2 (en) * 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6635173B2 (en) * 2000-12-28 2003-10-21 Cohesive Technologies, Inc. Multi column chromatography system
ES2178961B1 (es) * 2001-03-06 2004-07-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Fabricacion de nanoparticulas a base del copolimero de metil vinil eter y anhidrido maleico para la administracion de farmacos de naturaleza hidrofilica, en particular de bases puricas y pirimidinicas.
WO2003000226A2 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
EP1429749A2 (en) 2001-09-26 2004-06-23 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
US6960378B1 (en) 2002-06-27 2005-11-01 Rensselaer Polytechnic Institute Tubular microstructures via controlled nanoparticle assembly
ES2665464T3 (es) * 2003-03-28 2018-04-25 Sigmoid Pharma Limited Forma de dosificación oral sólida que contiene microcápsulas sin costuras
WO2005077337A2 (en) * 2004-02-05 2005-08-25 Baxter International Inc. Dispersions prepared by use of self-stabilizing agents
EP2444071A1 (en) * 2004-09-27 2012-04-25 Sigmoid Pharma Limited Minicapsule formulations
US7901711B1 (en) * 2006-04-17 2011-03-08 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof
US20110177306A1 (en) * 2004-12-17 2011-07-21 Mitsubishi Chemical Corporation Novel Core-Shell Structure
GB0501833D0 (en) * 2005-01-28 2005-03-09 Unilever Plc Carrier liquids and methods of production thereof
CA2656277A1 (en) * 2006-06-26 2008-01-03 Mutual Pharmaceutical Company, Inc. Active agent formulations, methods of making, and methods of use
WO2008040799A2 (en) * 2006-10-06 2008-04-10 Boehringer Ingelheim International Gmbh Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release
US20100068251A1 (en) * 2006-10-10 2010-03-18 Jina Pharmaceuticals, Inc. Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
CN103120653B (zh) * 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
EP2061587A1 (en) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP2010526053A (ja) * 2007-05-01 2010-07-29 シグモイド・ファーマ・リミテッド ニモジピン医薬組成物
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2009038591A1 (en) * 2007-09-17 2009-03-26 Yale University Bile salt colloids and methods of making and using thereof
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
EP2231169B1 (en) 2007-12-06 2016-05-04 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US20100159010A1 (en) * 2008-12-24 2010-06-24 Mutual Pharmaceutical Company, Inc. Active Agent Formulations, Methods of Making, and Methods of Use
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
KR20170054429A (ko) 2014-09-03 2017-05-17 제네세규스 인코포레이티드 치료용 나노입자 및 관련 조성물, 방법, 및 시스템
JP6716582B2 (ja) 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物
CA2997442C (en) 2015-09-04 2021-01-26 Yale University Polymeric bile acid nanocompositions targeting the pancreas and colon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US4711895A (en) * 1984-10-22 1987-12-08 Teijin Limited 4-hydroxy-2-cyclopentenone, process for production thereof, pharmaceutical composition comprising it
US5025004A (en) * 1988-06-13 1991-06-18 Eastman Kodak Company Water-dispersible polymeric compositions
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
JP2523926B2 (ja) * 1990-04-04 1996-08-14 松下電器産業株式会社 複合電話機
FR2660556B1 (fr) * 1990-04-06 1994-09-16 Rhone Poulenc Sante Microspheres, leur procede de preparation et leur utilisation.
FR2678168B1 (fr) * 1991-06-28 1993-09-03 Rhone Poulenc Rorer Sa Nanoparticules ayant un temps de capture par le dysteme reticulo endothelial allonge.
FR2678178A1 (fr) * 1991-06-28 1992-12-31 Rhone Poulenc Rorer Sa Procede de preparation de nanoparticules.
GB9300875D0 (en) * 1993-01-18 1993-03-10 Ucb Sa Nanocapsule containing pharmaceutical compositions

Also Published As

Publication number Publication date
PL317893A1 (en) 1997-04-28
ES2126905T3 (es) 1999-04-01
MX9606490A (es) 1997-03-29
AU2797995A (en) 1996-01-15
DE69506867T2 (de) 1999-06-24
US6146663A (en) 2000-11-14
BR9508363A (pt) 1997-11-04
DE69506867D1 (de) 1999-02-04
HU9603533D0 (en) 1997-02-28
CZ377296A3 (en) 1997-04-16
FI965165A0 (fi) 1996-12-20
FR2721510A1 (fr) 1995-12-29
CN1151114A (zh) 1997-06-04
FR2721510B1 (fr) 1996-07-26
FI965165A (fi) 1996-12-20
EP0766555A1 (fr) 1997-04-09
DK0766555T3 (da) 1999-08-23
ATE174791T1 (de) 1999-01-15
SK166696A3 (en) 1997-08-06
ZA955047B (en) 1996-02-09
WO1995035101A1 (fr) 1995-12-28
JP3806937B2 (ja) 2006-08-09
CA2192712A1 (fr) 1995-12-28
EP0766555B1 (fr) 1998-12-23
JPH10501804A (ja) 1998-02-17
NO965458L (no) 1996-12-18
HUT76549A (en) 1997-09-29

Similar Documents

Publication Publication Date Title
NO965458D0 (no) Stabiliserte nanopartikler som er filtrerbare under sterile betingelser
PT869776E (pt) Nanoparticulas estabilizadas e filtraveis em condicoes estereis
EP1607429A3 (en) Process for the preparation of aqueous dispersions of particles of water-soluble polymers
ATE345767T1 (de) Stabile wasser-in-öl emulsionssysteme
BR0110505A (pt) Sistemas de lentes oftálmicas
BR0001817A (pt) Composição em forma de emulsão óleo - em - água, utilização cosmética da composição, processo de tratamento cosmético, utilização da composição e utilização da associação de um organopolissiloxano sólido elastomérico reticulado e de um polìmero hidrossolúvel ou inchável na água
ES551371A0 (es) Procedimiento para preparar una dispersion acuosa estable, congelada, de un copolimero y una droga insoluble en agua. (como desglose y con prioridad de la patente espanola no. 544.580, presentada el 26 de junio de 1985).
DE69634491D1 (de) Vorrichtung zur senkung des augeninnendruckes
DE69616347T2 (de) O-Carboxymethylchitosan enthaltende Mittel und ihre Verwendung in Ophthalmika
ATE333867T1 (de) Emulgierte arzneistoffabgabesysteme
BR0005141A (pt) Emulsão cosmetica ou dematológica sem emulsionante, composição cosmética ou dermatológica destinada a fotoproteção da pele e/ou dos cabelos, utilização de emulsão e utilização de um polìmero associativo
MA23219A1 (fr) Emulsions aqueuses stables de tensio-actifs non ioniques
BR9508888A (pt) Agente de contraste utilização de um agente de contraste processos para gerar imagens melhoradas de um corpo humano ou de animal não humano e para preparar de um agente de contraste e um polímero polímeros biodegradáveis e implante cirúrgico
ATE288274T1 (de) Ophatlmologische zusammenssetzung
FR2737658B1 (fr) Composition cosmetique comprenant une dispersion aqueuse de polymere non ionique, utilisation et procede
DE69621521T2 (de) Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen
EP0813863A3 (en) A method for the preparation of stable aqueous suspensions, useful in pharmaceutical compositions
KR960037046A (ko) 도파민 수용기 자극제를 포함하는 근시 및 녹내장 치료용 안과 제형
KR900007438A (ko) 일본뇌염 백신 및 그의 제조방법